Nov 04, 2020
Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation
Nov 02, 2020
Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab
Nov 01, 2020
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development
Oct 28, 2020
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center
Sep 23, 2020
Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases
Sep 16, 2020
Samsung Biologics signs development agreement with Panolos for solid tumor treatment
Aug 10, 2020
Samsung Biologics to add fourth plant with growing demands
Aug 04, 2020
Samsung Biologics launches S-CHOice cell line expression technology
Jul 20, 2020
Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon
Jul 15, 2020
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement
Jul 11, 2020
Samsung Biologics signs additional development and manufacturing agreement with STCube
May 21, 2020
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio
May 19, 2020
Samsung Biologics Expands Business Continuity Excellence with Additional ISO 22301 Certification
Apr 09, 2020
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment
Apr 08, 2020
Samsung Biologics named Champion in 2020 CMO Leadership Awards
Apr 05, 2020
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
Mar 16, 2020
Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate
Mar 02, 2020
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Mar 02, 2020
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Mar 02, 2020
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug